Who are 64Cu-SAR-bisPSMA's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Rubidium-82, Tc-99m Pentetate, [Ga-68]PSMA, 18F-rhPSMA-7.3, Dexamethasone plus Radium-223, Ga-68-DOTATOC.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/64cu-sar-bispsma.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

64Cu-SAR-bisPSMA — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

64Cu-SAR-bisPSMA (64Cu-SAR-bisPSMA) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Radiopharmaceutical; PET imaging agent. Area: Oncology.

phase 3 Radiopharmaceutical; PET imaging agent PSMA (prostate-specific membrane antigen) Oncology Small molecule Live · refreshed every 30 min

Target snapshot

64Cu-SAR-bisPSMA (64Cu-SAR-bisPSMA) — Clarity Pharmaceuticals Ltd. 64Cu-SAR-bisPSMA is a copper-64 labeled radiopharmaceutical that binds to prostate-specific membrane antigen (PSMA) for positron emission tomography (PET) imaging of PSMA-expressing tumors.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
64Cu-SAR-bisPSMA TARGET	64Cu-SAR-bisPSMA	Clarity Pharmaceuticals Ltd	phase 3	Radiopharmaceutical; PET imaging agent	PSMA (prostate-specific membrane antigen)
Rubidium-82	Rubidium-82	Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)	marketed	PET radiopharmaceutical	Na+/K+-ATPase pump (myocardial uptake mechanism)
Tc-99m Pentetate	Tc-99m Pentetate	NYU Langone Health	marketed	Radiopharmaceutical diagnostic agent
[Ga-68]PSMA	[Ga-68]PSMA	Norbert Avril, M.D.	marketed	PET imaging agent / radiopharmaceutical	PSMA (prostate-specific membrane antigen)
18F-rhPSMA-7.3	18F-rhPSMA-7.3	Hackensack Meridian Health	marketed	PET imaging agent / radiopharmaceutical	PSMA (prostate-specific membrane antigen)
Dexamethasone plus Radium-223	Dexamethasone plus Radium-223	University Health Network, Toronto	marketed	Combination therapy: corticosteroid plus alpha-emitting radiopharmaceutical	Radium-223 targets calcium-mimetic bone uptake; dexamethasone targets glucocorticoid receptor
Ga-68-DOTATOC	Ga-68-DOTATOC	Weill Medical College of Cornell University	marketed	Radiopharmaceutical	Somatostatin receptors (SSTRs) on neuroendocrine tumor cells

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Radiopharmaceutical; PET imaging agent class)

Clarity Pharmaceuticals Ltd · 1 drug in this class
Radiomedix, Inc. · 1 drug in this class
Teva Branded Pharmaceutical Products R&D, Inc. · 1 drug in this class
UMC Utrecht · 1 drug in this class
University of Colorado, Denver · 1 drug in this class
University of Saskatchewan · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). 64Cu-SAR-bisPSMA — Competitive Intelligence Brief. https://druglandscape.com/ci/64cu-sar-bispsma. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing